Amir London Photo: Einat Levron Kamada withdraws European drug marketing request

The European Medicines Agency is demanding additional data that require another trial.

Teva  photo: Reuters Teva loses $235m patent trial to GSK

A US court dismissed Teva's claim that GlaxoSmithKline's patent for the Coreg drug was invalid.

Yaky Yanay Photo: Eyal Yizhar China's Innovative Medical cancels Pluristem investment

Pluristem blamed Chinese foreign current regulations, but the Chinese company said it was dissatisfied with the results of due diligence.

Lab Technician.  Photo: Reuters Women dominate Israel's life science industry

70% of employees are women says the Nisha placement company. Salaries are generous but not as high as in IT.

Eli Tilson Photo: Tomer Jacobson Pancho buys US Alzheimer's sheltered housing facility

The Israeli real estate company paid $17.5 million for the property.

Ron Babkov €20m EU loan to fund BiondVax Phase III flu vaccine trial

The Israeli company is developing a universal flu vaccination.

Gamida Cell Gamida Cell raises $40m

The financing round, led by new investor Shavit Capital, will support Gamida Cell's Phase 3 trial of its NiCord bone marrow transplantation product.

biomed Hadasit sells stem cell co Cell Cure stake

Hadasit sold its 21% stake in Cell Cure, which develops stem cell implants for treatment of retinal degeneration, to BioTime for $12.75 million.

Yitzhak Peterburg Photo: PR Peterburg: Teva facing its most challenging era

The interim Teva CEO told the Globes Capital Market Conference that he sees Amazon and Google as rivals as much as Mylan and Novartis.

drug development Neuroderm mulls several acquisition offers

The Israeli drug delivery company has a market cap of $658 million.

Teva  photo: Reuters Teva launches generic cholesterol treatment

Zetia, the brand version of the drug, had annual sales of $2.7 billion in the US in the year to March.

Teva  photo: Reuters Teva launches generic conjunctivitis treatment

Pataday had annual sales of $303 million in the US, according to IMS data as of March 2017.

Gabi Iddan, Liron Elia, Eitan Scapa  photo: PR Art Medical seeks to make hospitals safer

The company has developed a solution designed to reduce mortality among patients on respirators and fed through tubes. It has just raised $20 million.

bio, biotech, lab, microscope, medicine Israeli startup seeks to replace antibiotics

BiomX is planning future treatments for Crohn's Disease, colitis, and even cancer.

Assaf Keret, Yaron Bresky  photo: Gil Arbel RM Global to invest $30m in FutuRx biotech startups

RM Global Israel's Yaron Breski: Anyone not involved in breakthrough companies from the beginning won't have a foothold in the next scientific revolution.

Yaky Yanay Photo: Eyal Yizhar Number of life sciences cos up 50% in a decade

IATI: The trend in Israel is away from medical devices and towards digital medicine.

cancer Intra-body imaging co Body Vision maps lung cancer

Body Vision integrates a CT scan and X-ray in order to remove very small lung tumors that might develop into lung cancer.

Copaxone Teva embroiled in Copaxone dosage levels dispute

Proneuron claims in its legal battle with Teva that the Israeli pharmaceutical giant refused to consider lower dosage Copaxone.

Health Photo: Shutterstock ASAP Creative Healthcare meets big data

"Globes" profiles the 10 Israeli startups in the Reboot Forum 2017’s Leading Healthcare Initiative, presenting innovations based mainly on big data analytics.

Twitter Facebook Linkedin RSS Newsletters גלובס MAD Conference 2017